# Shionogi Inc., Florham Park, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/shionogi-inc/1ee5c238-9c75-4bdd-97e2-379adba1ce0e

> Inspection records and compliance data for Shionogi Inc. in Florham Park, New Jersey. 7 FDA inspections on record, last inspected February 13, 2026.

---

## Details

- Name: Shionogi Inc.
- FEI Number: 3008581870
- Address Line 1: 300 Campus Dr Ste 300
- City: Florham Park
- State: New Jersey
- Zip Code: 07932
- Country Name: United States
- Address: 300 Campus Dr Ste 300, Florham Park, New Jersey 07932, United States
- Country: United States

## Related Documents

- FDA Inspection 1305578 - Shionogi Inc. - 2026-02-13 — source: FDA, date: February 13, 2026
- FDA Inspection 1115062 - Shionogi Inc. - 2019-12-19 — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2019
- [FDA Inspection 1047601 - Shionogi Inc. - 2018-03-12](https://www.keypedia.com/records/fda_inspections/shionogi-inc/87462d3b-7c29-4c67-9036-135f0c378a59) — classification: No Action Indicated (NAI), source: FDA, date: March 12, 2018
- FDA Inspection 992012 - Shionogi Inc. - 2016-10-07 — classification: No Action Indicated (NAI), source: FDA, date: October 7, 2016
- FDA Inspection 948537 - Shionogi Inc. - 2015-11-17 — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2015
- [FDA Inspection 807882 - Shionogi Inc. - 2012-11-05](https://www.keypedia.com/records/fda_inspections/shionogi-inc/4133cce8-cb8f-45cc-87a5-99fc5c6faf1c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 5, 2012
- FDA Inspection 748084 - Shionogi Inc. - 2011-09-29 — classification: No Action Indicated (NAI), source: FDA, date: September 29, 2011

## Related Companies

- [Labcorp Drug Development](https://www.keypedia.com/companies/labcorp-drug-development/590644d8-047e-4701-b6f2-fcb4b881a7a1)
- [Orexo Us Inc](https://www.keypedia.com/companies/orexo-us-inc/ffd3c1cb-2627-43db-843c-68dc3aac6dc8)
- [Grissel Flores, APN](https://www.keypedia.com/companies/grissel-flores-apn/4a8c5e47-6bb8-4dab-9799-6ba53f18c300)
- [Symogen Inc.](https://www.keypedia.com/companies/symogen-inc/1675970b-2dad-45b8-a9f3-c86b8443747c)
- [Carran, Melissa A., MD](https://www.keypedia.com/companies/carran-melissa-a-md/37c61916-8c74-4bf2-9be5-b761ee91e0df)
- [Karlin, Gary S](https://www.keypedia.com/companies/karlin-gary-s/e2449085-6593-479e-a60c-a61d4569d0e5)
- [Aprecia Pharmaceuticals LLC](https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/e3881cd1-fc97-4d71-a008-3f8ba5e262c6)
- [NBN Infusions Inc](https://www.keypedia.com/companies/nbn-infusions-inc/d542f16e-21c3-4dd9-ac7f-093886b83750)
- [Actavis Totowa LLC](https://www.keypedia.com/companies/actavis-totowa-llc/359568bc-982e-45af-a0ee-af7da093fd1f)
- [ThromboGenics, Inc.](https://www.keypedia.com/companies/thrombogenics-inc/a2eb7767-b625-4d2c-acc7-8d38637210ba)